Bank of New York Mellon’s Kezar Life Sciences KZR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,426
| Closed | -$193K | – | 4197 |
|
|
2024
Q1 | $193K | Sell |
21,426
-796
| -4% | -$7.18K | ﹤0.01% | 3933 |
|
|
2023
Q4 | $211K | Sell |
22,222
-4,162
| -16% | -$39.4K | ﹤0.01% | 3934 |
|
|
2023
Q3 | $314K | Buy |
26,384
+440
| +2% | +$5.24K | ﹤0.01% | 3780 |
|
|
2023
Q2 | $636K | Buy |
25,944
+7,928
| +44% | +$194K | ﹤0.01% | 3460 |
|
|
2023
Q1 | $564K | Sell |
18,016
-204
| -1% | -$6.39K | ﹤0.01% | 3430 |
|
|
2022
Q4 | $1.28M | Buy |
18,220
+35
| +0.2% | +$2.46K | ﹤0.01% | 3075 |
|
|
2022
Q3 | $1.57M | Buy |
18,185
+3,387
| +23% | +$292K | ﹤0.01% | 2987 |
|
|
2022
Q2 | $1.22M | Sell |
14,798
-4,301
| -23% | -$356K | ﹤0.01% | 3109 |
|
|
2022
Q1 | $3.17M | Sell |
19,099
-84
| -0.4% | -$14K | ﹤0.01% | 2678 |
|
|
2021
Q4 | $3.21M | Buy |
19,183
+6,850
| +56% | +$1.15M | ﹤0.01% | 2710 |
|
|
2021
Q3 | $1.07M | Buy |
12,333
+1,114
| +10% | +$96.3K | ﹤0.01% | 3358 |
|
|
2021
Q2 | $609K | Buy |
11,219
+115
| +1% | +$6.24K | ﹤0.01% | 3677 |
|
|
2021
Q1 | $661K | Sell |
11,104
-162
| -1% | -$9.64K | ﹤0.01% | 3536 |
|
|
2020
Q4 | $588K | Buy |
11,266
+8
| +0.1% | +$418 | ﹤0.01% | 3535 |
|
|
2020
Q3 | $545K | Buy |
11,258
+1,086
| +11% | +$52.6K | ﹤0.01% | 3449 |
|
|
2020
Q2 | $527K | Buy |
10,172
+532
| +6% | +$27.6K | ﹤0.01% | 3440 |
|
|
2020
Q1 | $420K | Buy |
9,640
+4,833
| +101% | +$211K | ﹤0.01% | 3456 |
|
|
2019
Q4 | $192K | Sell |
4,807
-152
| -3% | -$6.07K | ﹤0.01% | 3921 |
|
|
2019
Q3 | $162K | Sell |
4,959
-251
| -5% | -$8.2K | ﹤0.01% | 3933 |
|
|
2019
Q2 | $402K | Buy |
5,210
+1,875
| +56% | +$145K | ﹤0.01% | 3700 |
|
|
2019
Q1 | $592K | Buy |
3,335
+1,593
| +91% | +$283K | ﹤0.01% | 3468 |
|
|
2018
Q4 | $411K | Buy |
+1,742
| New | +$411K | ﹤0.01% | 3580 |
|